… and piperacillin-tazobactam. Our results suggested that piperacillin-tazobactam can be as
… We were unable to ascertain if all patients received extended infusions. We attempted to …

… The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of extended-spectrum
β-lactamase (ESBL) bacteremia is controversial. We compared 14-day mortality of PTZ vs …

… comparing carbapenems to piperacillin-tazobactam among patients … A piperacillin-tazobactam
case was defined as a patient who was treated with ≥2 doses of piperacillintazobactam …

… infections caused by extended-spectrum b-lactamase (ESBL)-… to b-lactam–b-lactamase
inhibitor combinations, including … the use of more blactam–b-lactamase inhibitor compounds that …

… Beta-lactam/beta-lactamase inhibitor combination antimicrobials (… extended-spectrum-beta-lactamase
(ESBL)-producing Gram-negative bacteria (ESBL-GNR). Piperacillin-tazobactam (…

… dosing strategies of piperacillin-tazobactam against ESBL-producing Enterobacteriaceae.
Given the variability of clinical responses to piperacillin-tazobactam, we hypothesized that the …

… Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam
for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis. 2015;…

… Similarly, when discussing the generalizability of their findings, the investigators of the
landmark MERINO trial mention that “whether piperacillin-tazobactam remains effective for urinary …

… While piperacillin–tazobactam exhibits a broad spectrum of antibacterial activity, some
Gram-positive bacteria demonstrate intrinsic resistance to the antibiotic. Low affinity of …

… Piperacillin/tazobactam (TZP) as an alternative treatment to carbapenems for infections
involving extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-PE) …